Abbott Laboratories India

US and Canadian anti-trust regulators conditionally approve Abbott-Alere merger

29 Sep 2017

Abbott Laboratories patches heart devices that could pose cybersecurity risks

31 Aug 2017

After price cap, Abbot seeks to withdraw stents from India

22 Apr 2017

Abbott, Alere agree to end legal battles, to go ahead with merger at lower price

15 Apr 2017

US regulators grant conditional approval to Abbott’s acquisition of St. Jude Medical

28 Dec 2016

US antitrust regulators yesterday approved Abbott Laboratories proposed $25-billion acquisition of medical device maker St. Jude Medical Inc on condition that it divests two medical device businesses

Abbott seeks to terminate $5.8-bn acquisition of Alere

08 Dec 2016

Abbott Laboratories has filed a plaint to terminate its proposed acquisition of Alere Inc due to a "substantial loss" in the value of Alere since the merger agreement was signed

European regulator conditionally approves Abbott's $25-bn deal for St Jude Medical

24 Nov 2016

Abbott offers EU concessions for antitrust approval of St Jude Medical acquisition

04 Nov 2016

Abbott Laboratories to sell eye care business to Johnson & Johnson for $4.325 bn

17 Sep 2016

Alere sues Abbott for completion of $5.8-bn merger

29 Aug 2016

Abbott to buy medical device maker St. Jude Medical for $25 bn

28 Apr 2016

P&G follows Pfizer, Abbot, ends sale of cold remedy

15 Mar 2016

India bans Pfizer, Abbot cough syrups; shares tank

14 Mar 2016

The centre has banned Pfizer’s Corex and Abbot Laboratories’ Phensedyl after a panel of experts found the codeine-based drugs had ‘no therapeutic justification’ and were leading to addiction as well as smuggling

Abbott to buy rapid diagnostic testing provider Alere for $5.8 bn

02 Feb 2016

The acquisition will enable Abbott to become the leading provider of point of care diagnostic testing with total sales exceeding $7 billion from $4.6 billion currently

Sanofi, Pfizer, Abbott eye Mexican generic drug maker Rimsa

21 Sep 2015

New intraocular lens helps cataract-affected see better

07 Aug 2015

Abbott Laboratories to back Mylan-Perrigo deal

17 Jun 2015

Maruti joins Boeing, Abbott, Honeywell to back India’s IPR regime

04 Jun 2014

The support comes against a backdrop of US industry and trade lobbies objecting to India's rejection of patents for Bristol-Myers Squibb's Sprycel and Novartis AG's Glivec

Abbott to acquire Chile's CFR Pharmaceuticals in a $2.9 bn deal

17 May 2014

This is  Abbott’s first multi-billion dollar deal after it spun off some of its research-based pharmaceuticals business last year

Abbott Laboratories seeks to sell mature drugs worth more than $5 bn: report

05 May 2014

Abbott to enter laser cataract surgery market through OptiMedica acquisition

16 Jul 2013

Abbott to acquire stent maker IDEV Technologies for $310 mn

15 Jul 2013

Abbott buying OptiMedica for $400 mn to enter laser cataract surgery market

15 Jul 2013

Russia blocks Abbott Laboratories - Petrovax merger

20 Apr 2013

The deal would have made Abbott the first overseas pharmaceutical company to own vaccine manufacturing facilities in Russia.

Pfizer, Novartis, Abbott in race for Brazil’s Ache Laboratorios: report

03 Apr 2013